- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
A new institute for pediatric medical devices is pushing for progress and innovation in this frequently overlooked market. The Sheikh Zayed Institute for Pediatric Surgical Innovation (affiliated with the Children’s National Health System) was opened in April 2011, thanks to a $150 million gift from the government of Abu Dhabi. According to an article on …
A new institute for pediatric medical devices is pushing for progress and innovation in this frequently overlooked market. The Sheikh Zayed Institute for Pediatric Surgical Innovation (affiliated with the Children’s National Health System) was opened in April 2011, thanks to a $150 million gift from the government of Abu Dhabi.
According to an article on MedCityNews:
[The institute] has funding available to help startups jumpstart their pediatric medical device ideas – and is supporting about 40 at present.
That’s because the so-called “valley of death” in startup formation is hard to traverse for pediatric medical device companies in particular. This is because venture capitalists are reluctant to support upstarts if their products haven’t yet been derisked. And, frankly, the pediatric device market is so niche that it’s risky from the get-go.
So the Institute serves as a device-derisking incubator, with aims to help entrepreneurs with business planning, regulatory support, clinical trials, prototyping and preclinical work. Because the Institute is directly affiliated with a children’s hospital, the innovators have ready access to field experts and patient populations.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.